Although the highest S100B concentration in the group of T2DM patients whose blood was collected after COVID-19 was only 700 pg/mL, this protein was detectable at CS100B ≥ 7.8 pg/mL in 79% of participants in the group. Here, S100B is linked to COVID-19.